BackgroundCanine distichiasis is a well-known cause of ocular irritation and excessive lacrimation (secretion of tears) in the dog. The term distichiasis originates from the Greek words di and stichos meaning two and rows, respectively, and as the name implies, the condition is characterized by an additional row of cilia, which erupts on the eyelid margin. Many purebred dogs are known to be predisposed to the condition, with many affected individuals within the populations. Even though the problem is widespread, the exact mode of inheritance and the heredity has not been studied extensively. However, some degree of genetic influence has been assumed, due to the high incidences within specific breeds. In the present study we have examined a cohort of English Cocker spaniels in Denmark to determine the prevalence and heritability of the disease.ResultsData from English Cocker spaniels with an ECVO eye examination registered between 2004–2013 were included in the study. The number of dogs examined during this period was 799, and the prevalence of distichiasis within this cohort was estimated at 49.31 % with a gender predisposition that females are more likely to get distichiasis than males. The correlation between the distichiasis status of the parents and their offspring revealed a significant association between the breeding combination of the parents and the occurrence of distichiasis in the offspring (p <0.0001). A relative risk (RR) ranging from 1.3 to 1.8 demonstrates that offspring of two affected parents are more likely to be affected than offspring descending from either one or two unaffected parents. The heritability was estimated to be moderate to high, i.e., 0.22 to 0.51.ConclusionsThe prevalence of distichiasis in English Cocker spaniels from Denmark, examined in 2004–2013 was shown to be extremely high. The relative risk of developing the disease was 1.3 and 1.8 for offspring of one or two affected parents respectively. This together with the moderate to high heritability of the condition indicates that selective breeding could be used to reduce the incidence of distichiasis.
Collie eye anomaly (CEA) is a congenital, inherited ocular disorder which is widespread in herding breeds. Clinically, the two major lesions associated with CEA are choroidal hypoplasia (CH) and coloboma, and both lesions are diagnosed based on ophthalmological examination. A 7.8-kb intronic deletion in the gene encoding non-homologous end-joining factor 1 (NHEJ1) has been reported to be the causative mutation underlying CH when present in the homozygous state. In this study, we have investigated the compliance between the clinical and genetic diagnosis of CH in the Danish Rough Collie and Shetland Sheepdog populations. Our results show that the deletion in NHEJ1 is not predictive for CH in the Danish Rough Collie population, whereas the clinical and genetic diagnosis is in accordance with each other in the Shetland Sheepdog population. Based on these results, it can be concluded that the intronic deletion in NHEJ1 is not the causative mutation but, rather, a marker linked to the locus underlying the trait in some populations but linked to both the wild-type and CH-causing locus in most dogs in the Danish Rough Collie population.
Key Clinical MessageB‐cell lymphoblastic lymphoma is an aggressive malignant disease. Necropsy and microscopical examination revealed widespread disease with a high proliferation index. This is the first reported case of B‐cell lymphoblastic lymphoma presenting in the ocular region and only the second reported lymphoma of the nictitating membrane.
The diagnosis was keratoacanthoma and this is the first reported keratoacanthoma of the spectacle in a reptile. Keratoacanthoma should be considered as a differential diagnosis when trying to remove retained spectacles from a reptile eye.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.